Search results
Author(s):
Shunmuga Sundaram Ponnusamy
,
Pugazhendhi Vijayaraman
Added:
2 years ago
Author(s):
Fang Fang
,
Zhou Yu Jie
,
Luo Xiu Xia
,
et al
Added:
3 years ago
The prevalence of heart failure (HF) is still high1 and is rising in developing countries.2 Despite optimal medical therapy, refractory HF is a common occurrence and remains a “global disease requiring global response.”3 The emergence of cardiac resynchronisation therapy (CRT), has brought a new paradigm in the management of HF. CRT has been the most promising device therapy in mild-to-severe HF…
View more
Author(s):
Sunil K Nadar
,
Muhammad Mujtaba Shaikh
Added:
3 years ago
The National Institutes of Health Biomarkers Definitions Working Group define a biomarker as “a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention”.1 Biomarkers have become increasingly important in current medical practice as they offer an easy way to either…
View more
Author(s):
Reinaldo B Bestetti
Added:
3 years ago
More than a century after its discovery, Chagas disease still is a major health problem in Latin America, with 5.7 million people in 21 countries being affected by it.1 Moreover, about 70 million people are at risk of acquiring the illness.1 Cases of Chagas disease are now found globally; there are more than 400,000 immigrants with this disease living in Europe (mainly in Spain, Italy and France)…
View more
Author(s):
Patrik Bachtiger
,
Carla M Plymen
,
Punam A Pabari
,
et al
Added:
3 years ago
Although cardiovascular disease is the leading cause of death globally, an increasing proportion of patients are surviving with heart failure (HF), which is substantially increasing in incidence and prevalence.1,2 In the management of HF the indications for implanted devices have widened, resulting in more patients living with an expanding variety of sensor-enabled implanted devices than any…
View more
Heart Block Post-TAVR
Author(s):
Anthony J Mazzella
,
Sameer Arora
,
Michael J Hendrickson
,
et al
Added:
2 years ago
Article
Author(s):
Juan Carlos López-Azor
,
Noelia de la Torre
,
María Dolores García-Cosío Carmena
,
et al
Added:
1 year ago
Author(s):
Martin R Cowie
,
Holger Woehrle
,
Olaf Oldenburg
,
et al
Added:
3 years ago
Heart Failure
In developed countries, approximately 1–2 % of the adult population has heart failure (HF), and the prevalence of this cardiovascular disease increases with age.1,2 HF can occur in the presence or absence of reduced left ventricular ejection fraction (LVEF), known as HF with reduced ejection fraction (HF-rEF) and HF with preserved ejection fraction (HF-pEF), respectively. The most…
View more
Author(s):
Douglas Bradley
Added:
1 year ago
ESC 22 - In this short interview filmed onsite at ESC Congress 2022, Dr Douglas Bradley (University of Toronto, Toronto, CA) discusses the findings of the ADVENT-HF Trial (NCT01128816).
ADVENT-HF was designed to determine if a respiratory device, Adaptive Servo Ventilation can reduce the risk of cardiovascular hospitalisations and death in patients with heart failure and sleep apnoea. 732…
View more
Author(s):
Robert D Adam
,
James Shambrook
,
Andrew S Flett
Added:
3 years ago
The current lifetime risk of heart failure is approximately one in three and the prognosis remains poor.1 The latest UK heart failure audit data reveal inpatient and 1-year mortality rates of 10% and 27%, respectively.2
The aetiology of heart failure is diverse, and many patients have several cardiac and non-cardiac pathologies that conspire to cause the syndrome. Currently the most common cause…
View more